Normal ESR, CRP and Platelet Count in Giant Cell Arteritis and Polymyalgia Rheumatica: A Diagnostic Conundrum
- PMID: 35265557
- PMCID: PMC8900556
- DOI: 10.12890/2022_003192
Normal ESR, CRP and Platelet Count in Giant Cell Arteritis and Polymyalgia Rheumatica: A Diagnostic Conundrum
Abstract
Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are both rheumatological diseases of the elderly with a strong association with each other and which rarely present with normal inflammatory markers. Here we present the case of a 61-year-old Caucasian woman who had typical symptoms of both diseases. At the time of presentation, her blood work showed normal inflammatory markers, but because of the high clinical suspicion for GCA, a temporal artery biopsy was done which was positive for giant cells and disruption of the internal elastic lamina. Our patient responded very well to treatment with oral steroids and steroid-sparing medication and was able to return to her normal life without experiencing any complications of the disease. By sharing our case, we aim to increase the awareness of medical personnel regarding the importance of focusing on the clinical presentation as well as the laboratory and pathological aspects of diagnosing GCA and PMR.
Learning points: Normal levels of inflammatory markers like C-reactive protein and the erythrocyte sedimentation rate do not rule out the diagnosis of giant cell arteritis (GCA).We aim to increase clinician recognition and awareness of other parameters, particularly the clinical presentation, that should be considered when diagnosing GCA or polymyalgia rheumatica.If the index of suspicion for the disease is high, it is crucial to start treatment as early as possible for better management and to avoid harmful complications.
Keywords: CRP; ESR; Giant cell arteritis; inflammatory markers; polymyalgia rheumatica; vasculitis.
© EFIM 2022.
Conflict of interest statement
Conflicts of Interests: The authors declare there are no competing interests.
Similar articles
-
Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.Drugs Aging. 2011 Aug 1;28(8):651-66. doi: 10.2165/11592500-000000000-00000. Drugs Aging. 2011. PMID: 21812500 Review.
-
Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.Semin Arthritis Rheum. 2001 Feb;30(4):257-71. doi: 10.1053/sarh.2001.9734. Semin Arthritis Rheum. 2001. PMID: 11182026 Review.
-
New-Onset Polymyalgia Rheumatica Complicated by Giant Cell Arteritis Following COVID-19 Infection.Cureus. 2023 Jul 16;15(7):e41951. doi: 10.7759/cureus.41951. eCollection 2023 Jul. Cureus. 2023. PMID: 37588300 Free PMC article.
-
Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.Front Immunol. 2019 Aug 22;10:1981. doi: 10.3389/fimmu.2019.01981. eCollection 2019. Front Immunol. 2019. PMID: 31507597 Free PMC article.
-
Polymyalgia Rheumatica and Giant Cell Arteritis: A Geriatric Perspective.Cureus. 2025 Mar 20;17(3):e80880. doi: 10.7759/cureus.80880. eCollection 2025 Mar. Cureus. 2025. PMID: 40255842 Free PMC article.
Cited by
-
Normal inflammatory markers in giant cell arteritis: a diagnostic blind spot.Rheumatol Int. 2025 Jul 19;45(8):175. doi: 10.1007/s00296-025-05930-3. Rheumatol Int. 2025. PMID: 40682608
-
New-onset giant cell arteritis with lower ESR and CRP level carries a similar ischemic risk to other forms of the disease but has an excellent late prognosis: a case-control study.Rheumatol Int. 2023 Jul;43(7):1323-1331. doi: 10.1007/s00296-023-05299-1. Epub 2023 Apr 7. Rheumatol Int. 2023. PMID: 37024620
-
Clinical Diagnosis of Temporal Arteritis With Seronegative and Negative Biopsy Studies.Cureus. 2022 Nov 2;14(11):e31011. doi: 10.7759/cureus.31011. eCollection 2022 Nov. Cureus. 2022. PMID: 36475126 Free PMC article.
-
Silent Inflammation: A Case of Blurry Vision Raising Diagnostic Challenges in an Elderly Patient.Cureus. 2024 Nov 30;16(11):e74822. doi: 10.7759/cureus.74822. eCollection 2024 Nov. Cureus. 2024. PMID: 39737319 Free PMC article.
-
Method Comparison of Erythrocyte Sedimentation Rate Automated Systems, the VES-MATIC 5 (DIESSE) and Test 1 (ALIFAX), with the Reference Method in Routine Practice.J Clin Med. 2024 Feb 1;13(3):847. doi: 10.3390/jcm13030847. J Clin Med. 2024. PMID: 38337540 Free PMC article.
References
-
- Maz M, Chung SA, Abril A, Langford CA, Gorelik M, Guyatt G, et al. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of giant cell arteritis and Takayasu arteritis. Arthritis Rheumatol. 2021;73(8):1349–1365. - PubMed
-
- González-Gay MA, Matteson EL, Castañeda S. Polymyalgia rheumatica. Lancet. 2017;390(10103):1700–1712. - PubMed
-
- Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33(8):1122–1128. - PubMed
-
- Turesson C, Börjesson O, Larsson K, Mohammad AJ, Knight A. Swedish Society of Rheumatology 2018 guidelines for investigation, treatment, and follow-up of giant cell arteritis. Scand J Rheumatol. 2019;48(4):259–265. - PubMed
-
- Dasgupta B, Cimmino MA, Maradit-Kremers H, Schmidt WA, Schirmer M, Salvarani C, et al. 2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2012;71(4):484–492. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous